Pharmaceutical Raw Materials
Veterinary API
Pharmaceutical Intermediates
Biochemicals
Pharmaceutical Excipients
Other Chemical Drugs
Blood System Drugs
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Antibiotics
Synthetic Anti Infective Drugs
Antipyretic Analgesics
Antiallergic Drugs
Fluid, Electrolyte, and Acid-Base Balance
Vitamins and Minerals Medicines
Urinary System Drugs
Digestive System Drugs
Antiparasitic Drugs
Anesthetic Agents
Hormones and Endocrine Drugs
Diagnostic Agents
Circulatory System Drugs
Immune System Medication
Anti Stress Drugs
Inhibitors
Drug Metabolism
Specialty Drugs
Feed Drug Additive
CAS:17479-19-5
Molecular Formula:C35H41N5O5
Alias
More Information
Ergocristine,9,10-Dihydro; Ergocristine,Dihydro; Dihydroergocristin; Dhec; Unii-05D48Lum4Z
Brief Introduction
Dihydroergocristine is an ergot alkaloid. Alongside dihydroergocornine and dihydroergocryptine, it is one of the components of ergoloid mesylates.
CAS:175414-77-4
Molecular Formula:C18H19N5O4S
Brief Introduction
Voreloxin (SNS-595; Vosaroxin; AG 7352) is a novel topoisomerase II inhibitor, which can induce DNA double strand break, block G2 phase and finally apoptosis.
CAS:1764-85-8
Molecular Formula:C10H11ClF3N3O4S3
Alias
More Information
Epithiazide [Usan]; Epithiazide; Epitizide; Epitizidum; P 2105; Epitizid
Brief Introduction
Epitizide is a diuretic. It is often combined with triamterene.
CAS:17692-24-9
Molecular Formula:C20H15NO4
Alias
More Information
La271A; Bisoxatine; Einecs 241-681-6; Bisoxatin; Bisoxatina; Bisoxatinum; Unii-7C75N0L7Fp; 7C75N0L7Fp
Brief Introduction
Bisoxatin is a stimulant laxative which increases peristalsis and inhibits absorbtion of water and ions in the intestine. It is marketed in Belgium under the tradename Wylaxine and used for the treatment of constipation and for preparation of the colon for surgical procedures.
CAS:177036-94-1
Molecular Formula:C22H22N2O4
Alias
More Information
Letairis; (S)-2-(4,6-Dimethylpyrimidin-2-Yloxy)-3-Methoxy-3,3-Diphenylpropanoic Acid; Unii-Hw6Nv07Qec; Ambrisentan; Volibris; Bsf 208075
Brief Introduction
Ansentan is a selective antagonist of ETA. Blocking ETA activation by ET-1 reduces vasoconstriction and potential smooth muscle cell proliferation involved in the pathogenesis of pulmonary hypertension. Increase pulmonary artery blood flow. Ansentan is a highly selective antagonist of ETA, which retains the production of ETB mediated vasodilators nitric oxide and prostacyclin.
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!